Citrus aurantium Naringenin Prevents Osteosarcoma Progression and Recurrence in the Patients Who Underwent Osteosarcoma Surgery by Improving Antioxidant Capability

Table 5

Osteosarcoma volume and metastasis after average two-year follow-up.

	Naringenin group ()	Control group ()	values
Osteosarcoma volume	106.3 ± 92.7 c.c.	225.8 ± 141.4 c.c.	0.01
Pulmonary metastasis, n (%)	7 (15.6)	9 (20.0)	0.58
Other bone metastasis, n (%)	5 (11.1)	6 (13.3)	0.75

Note: 2 died in naringenin group and 3 died in control group after a two-year follow-up. via a control group.